Login to Your Account

NewCo News

Inventiva Emerges from Solvay Lab Buyout with R&D Engine

By Nuala Moran
Staff Writer

Wednesday, September 26, 2012
LONDON – A new-look, 80-strong small-molecule drug discovery and development company has emerged from Abbott, following the management buyout of the former Solvay Pharmaceuticals R&D laboratory in Dijon, France.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription